Grimm, H. P., Schumacher, V., Schäfer, M., Imhof-Jung, S., Freskgård, P., Brady, K., . . . Janssen, N. (2023). Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. Taylor & Francis Group.
Chicago Style (17th ed.) CitationGrimm, Hans Peter, et al. Delivery of the Brainshuttle™ Amyloid-beta Antibody Fusion Trontinemab to Non-human Primate Brain and Projected Efficacious Dose Regimens in Humans. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationGrimm, Hans Peter, et al. Delivery of the Brainshuttle™ Amyloid-beta Antibody Fusion Trontinemab to Non-human Primate Brain and Projected Efficacious Dose Regimens in Humans. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.